Literature DB >> 28098380

British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.

D de Berker1, J M McGregor2, M F Mohd Mustapa3, L S Exton3, B R Hughes4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28098380     DOI： 10.1111/bjd.15107

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  29 in total

1.  Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015.

Authors:  Howa Yeung; Marissa L Baranowski; Robert A Swerlick; Suephy C Chen; Jennifer Hemingway; Danny R Hughes; Richard Duszak
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

Review 2.  Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

Authors:  Nathalie C Zeitouni; Neal Bhatia; Roger I Ceilley; Joel L Cohen; James Q Del Rosso; Angela Y Moore; Gilly Munavalli; David M Pariser; Todd Schlesinger; Daniel M Siegel; Andrea Willey; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

3.  Attitudes among dermatologists regarding actinic keratosis treatment options.

Authors:  Gaia Moretta; Tonia Samela; Francesca Sampogna; Francesco Ricci; Fabio Carlesimo; Annarita Panebianco; Angelo Massimiliano D'Erme; Giovanni Di Lella; Sabatino Pallotta; Elena Dellambra; Damiano Abeni; Luca Fania
Journal:  Dermatol Reports       Date:  2022-01-31

4.  Approaches to Field Therapy for Actinic Keratoses: Relating Clinical Trial Results to Real-world Practice-A Commentary.

Authors:  David M Pariser
Journal:  J Clin Aesthet Dermatol       Date:  2022-04

5.  Drug Intake and Actinic Keratosis: A Case-Control Study.

Authors:  Andrea Sechi; Ambra di Altobrando; Eugenio Cerciello; Elisa Maietti; Annalisa Patrizi; Francesco Savoia
Journal:  Dermatol Pract Concept       Date:  2021-04-12

Review 6.  A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.

Authors:  Laura Del Regno; Silvia Catapano; Alessandro Di Stefani; Simone Cappilli; Ketty Peris
Journal:  Am J Clin Dermatol       Date:  2022-02-19       Impact factor: 6.233

7.  A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis.

Authors:  Anja Wessely; Theresa Steeb; Franz Heppt; Annkathrin Hornung; Matthias D Kaufmann; Elias A T Koch; Frédéric Toussaint; Michael Erdmann; Carola Berking; Markus V Heppt
Journal:  Curr Oncol       Date:  2021-02-19       Impact factor: 3.677

8.  Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses.

Authors:  Khaled Ezzedine; Caroline Painchault; Melanie Brignone
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

9.  Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.

Authors:  Athina Angelopoulou; Nikos Alexandris; Evangelia Konstantinou; Konstantinos Mesiakaris; Charilaos Zanidis; Konstantinos Farsalinos; Konstantinos Poulas
Journal:  Environ Res       Date:  2020-06-23       Impact factor: 6.498

10.  Cytoplasmic Increase in Hsp70 Protein: A Potential New Biomarker of Early Infiltration of Cutaneous Squamous Cell Carcinoma Arising from Actinic Keratosis.

Authors:  Montserrat Fernández-Guarino; José Javier Zamorano León; Antonio José López Farré; Maria Luisa González Morales; Ana Isabel Sánchez Adrada; José Barrio Garde; Jose Antonio Arias Navalon; Pedro Jaén Olasolo
Journal:  Cancers (Basel)       Date:  2020-05-03       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.